Benitec Biopharma Limited is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.
The company’s chairman announced at the Benitec Biopharma’s Annual General Meeting for 2016 that, “Lastly with OPMD, we have initiated animal testing experiments with our clinical vector to ‘knockdown and replace’ the molecular target that leads to the diseased condition in humans”. Read full article.
Benitec Biopharma Ltd. engages in the development of therapeutics based on patented gene-silencing technology called ddRNAi or RNAi. It operates through the Australia and United States of America geographical segments. The company was founded by Kenneth C. Reed in 1997 and is headquartered in Melbourne, Australia. [Source: MarketWatch]